Janiczek Wealth Management LLC increased its position in shares of The Cigna Group (NYSE:CI – Free Report) by 2.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,030 shares of the health services provider’s stock after purchasing an additional 54 shares during the period. Janiczek Wealth Management LLC’s holdings in The Cigna Group were worth $737,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also added to or reduced their stakes in CI. Seizert Capital Partners LLC increased its stake in The Cigna Group by 195.8% during the 4th quarter. Seizert Capital Partners LLC now owns 32,150 shares of the health services provider’s stock worth $9,627,000 after acquiring an additional 21,280 shares during the period. Roman Butler Fullerton & Co. increased its stake in The Cigna Group by 61.4% during the 4th quarter. Roman Butler Fullerton & Co. now owns 9,307 shares of the health services provider’s stock worth $2,772,000 after acquiring an additional 3,539 shares during the period. TFO Wealth Partners LLC increased its stake in The Cigna Group by 98,980.0% during the 4th quarter. TFO Wealth Partners LLC now owns 4,954 shares of the health services provider’s stock worth $1,497,000 after acquiring an additional 4,949 shares during the period. Ellsworth Advisors LLC bought a new position in The Cigna Group during the 4th quarter worth $4,377,000. Finally, Sapient Capital LLC bought a new position in The Cigna Group during the 4th quarter worth $2,811,000. 86.99% of the stock is owned by institutional investors and hedge funds.
The Cigna Group Trading Down 0.9 %
Shares of NYSE:CI traded down $3.04 during midday trading on Thursday, reaching $334.54. The company’s stock had a trading volume of 326,505 shares, compared to its average volume of 1,606,670. The firm has a market capitalization of $95.03 billion, a price-to-earnings ratio of 27.52, a PEG ratio of 1.03 and a beta of 0.53. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.71 and a current ratio of 0.71. The firm has a 50 day moving average price of $341.96 and a two-hundred day moving average price of $332.69. The Cigna Group has a fifty-two week low of $253.95 and a fifty-two week high of $365.71.
The Cigna Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 20th. Shareholders of record on Tuesday, June 4th were issued a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a yield of 1.67%. The ex-dividend date of this dividend was Tuesday, June 4th. The Cigna Group’s dividend payout ratio is currently 45.98%.
Insiders Place Their Bets
In other news, Director Elder Granger sold 547 shares of the company’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $331.38, for a total value of $181,264.86. Following the completion of the transaction, the director now directly owns 5,471 shares of the company’s stock, valued at $1,812,979.98. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, Director Elder Granger sold 547 shares of the company’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $331.38, for a total value of $181,264.86. Following the transaction, the director now owns 5,471 shares in the company, valued at $1,812,979.98. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the company’s stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $348.71, for a total value of $2,073,429.66. Following the completion of the transaction, the senior vice president now owns 2,595 shares in the company, valued at approximately $904,902.45. The disclosure for this sale can be found here. In the last ninety days, insiders sold 22,988 shares of company stock valued at $7,975,726. Corporate insiders own 0.60% of the company’s stock.
Analyst Ratings Changes
Several brokerages have recently issued reports on CI. Morgan Stanley reiterated an “overweight” rating and issued a $392.00 price target (up previously from $382.00) on shares of The Cigna Group in a research note on Monday, March 4th. Oppenheimer lifted their price target on The Cigna Group from $370.00 to $400.00 and gave the company an “outperform” rating in a research note on Friday, May 3rd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $400.00 price target on shares of The Cigna Group in a research note on Wednesday, June 12th. Piper Sandler began coverage on The Cigna Group in a research note on Wednesday. They issued an “overweight” rating and a $400.00 price target on the stock. Finally, Robert W. Baird began coverage on The Cigna Group in a research note on Thursday, May 30th. They issued an “outperform” rating and a $388.00 price target on the stock. Two analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, The Cigna Group presently has an average rating of “Buy” and a consensus target price of $376.20.
Get Our Latest Research Report on CI
The Cigna Group Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Recommended Stories
- Five stocks we like better than The Cigna Group
- Low PE Growth Stocks: Unlocking Investment Opportunities
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Progress Software Stock Back in the Green After Beating Forecasts
- Trading Stocks: RSI and Why it’s Useful
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.